Molecular mechanisms for uremic toxin-induced oxidative tissue damage via a cardiovascular-renal connection

Hiroshi Watanabe1

  • 1Department of Biopharmaceutics, School of Pharmacy, Kumamoto University, 5-1 Oe-honmachi, Chuo-ku, Kumamoto 862-0973, Japan. hnabe@kumamoto-u.ac.jp

Insights

Protein-bound uremic toxins like indoxyl sulfate (IS) and p-cresyl sulfate (PCS) contribute to chronic kidney disease (CKD) and cardiovascular disease (CVD) progression. Understanding their role in oxidative damage is key to developing new treatments.

Area of Science:

  • Nephrology
  • Cardiology
  • Toxicology

Background:

  • Chronic kidney disease (CKD) leads to dialysis and cardiovascular disease (CVD).
  • CKD affects 13.3 million people in Japan, with 300,000 on hemodialysis.
  • Preventing dialysis and CVD deaths is a public health priority, but CKD-CVD mechanisms are unclear.

Purpose of the Study:

  • Investigate the role of protein-bound uremic toxins in CKD and CVD.
  • Examine the relationship between the redox properties of these toxins and CKD-CVD pathogenesis.
  • Focus on indoxyl sulfate (IS) and p-cresyl sulfate (PCS) to understand molecular mechanisms.

Main Methods:

  • Review of recent studies on uremic toxins, oxidative stress, and cardiovascular-renal connections.
  • Analysis of the impact of IS and PCS on CKD-CVD progression.
  • Examination of redox properties of specific uremic toxins.

Main Results:

  • Protein-bound uremic toxins, difficult to remove by hemodialysis, play a role in CKD and CVD.
  • Indoxyl sulfate (IS) and p-cresyl sulfate (PCS) are implicated in CKD-CVD pathogenesis.
  • These toxins induce oxidative tissue damage through a cardiovascular-renal connection.

Conclusions:

  • Uremic toxins like IS and PCS contribute to CKD-CVD via oxidative stress.
  • Understanding these molecular mechanisms is crucial for novel therapeutic strategies.
  • Targeting uremic toxin-induced damage may prevent dialysis and reduce cardiovascular mortality.

Related Concept Videos

Chronic Kidney Disease II: Clinical Manifestations01:24

Chronic Kidney Disease II: Clinical Manifestations

Chronic Kidney Disease (CKD) progressively impairs multiple body systems due to the accumulation of uremic toxins, which disrupt cellular functions across various organs.Neurologic symptomsNeurologic symptoms often arise early in CKD, as uremic toxin buildup drives changes in cognitive and motor functions. Patients frequently experience fatigue, headache, confusion, difficulty concentrating, and, in severe cases, seizures. Peripheral neuropathy commonly manifests as burning sensations in the...
Bioactivation and Tissue Toxicity01:25

Bioactivation and Tissue Toxicity

Bioactivation is a metabolic process that transforms less reactive substances into highly reactive metabolites, initiating tissue toxicity. This transformation can lead to various toxic effects, including carcinogenesis and teratogenesis. Reactive metabolites are classified into two main types: electrophiles and free radicals.Electrophiles are electron-deficient species and are produced primarily by the enzyme cytochrome P-450 during the metabolism of compounds containing carbon, nitrogen, or...
Acute Kidney Injury II: Pathophysiology01:29

Acute Kidney Injury II: Pathophysiology

Acute kidney injury (AKI) causes are categorized into three primary categories based on the location of the injury: prerenal, intrarenal (or intrinsic), and postrenal causes. This classification guides clinical management and illustrates how different pathways can impair kidney function.Etiology and Pathophysiology of Acute Kidney Injury1. Prerenal causesEtiology: Prerenal Acute Kidney Injury, the most common type, occurs when reduced blood flow to the kidneys decreases filtration capacity...
Cellular Injury I: Introduction01:00

Cellular Injury I: Introduction

Cellular injury occurs when a cell cannot maintain homeostasis or adapt to stressors such as hypoxia, toxins, or trauma. Depending on severity and duration, injury may be reversible, allowing recovery, or irreversible, leading to cell death.General Mechanisms of Cell InjuryAlthough causes vary, most cellular injuries arise from a few key mechanisms that disrupt essential functions and often amplify one another. Cell survival depends on the extent and balance of these disturbances.ATP depletion...
Drug Toxicity: Dose-Dependent Reactions01:24

Drug Toxicity: Dose-Dependent Reactions

Drug toxicities can be stratified into pharmacological, pathological, or genotoxic based on their mechanisms. The incidence and severity of these toxicities generally increase with the drug's concentration in the body and exposure time.Pharmacological toxicity is evident when the therapeutic effects of drugs overshoot into adverse reactions in a predictable, dose-dependent manner. Central nervous system (CNS) depression from barbiturates is a classic example, with effects escalating from...
Cellular Injury IV: Necrosis01:16

Cellular Injury IV: Necrosis

Necrosis is a form of irreversible cell death caused by severe injury such as ischemia, toxins, or trauma. Unlike programmed cell death, it is an uncontrolled, pathological process that typically provokes inflammation in surrounding tissues.Pathophysiologic ChangesNecrosis begins when cells sustain critical damage, leading to swelling of organelles, particularly mitochondria, and rapid ATP depletion. As energy levels decline, membrane ion pumps fail, leading to calcium influx and eventually,...